BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1101946)

  • 1. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
    Utian WH; Begg G; Vinik AI; Paul M; Shuman L
    Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation.
    Yuen BH; Pendleton HJ; Blair S
    Can Med Assoc J; 1977 Oct; 117(8):919-21. PubMed ID: 334356
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
    Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L
    Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactation-inhibiting and prolactin-lowering effect of lisuride and bromocriptine: a comparative study.
    Van Dam LJ; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):323-30. PubMed ID: 7333409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of postpartum lactation using a new ergot derivative: 2-Br-alpha-ergocryptine or CB-154. Comparison with chlorotrianisene].
    Dexeus Trias de Bes J
    Gynakol Rundsch; 1975; 15(1):91-6. PubMed ID: 1243823
    [No Abstract]   [Full Text] [Related]  

  • 6. Breastfeeding. Suppressing lactation.
    Eaton J
    Nurs Times; 1991 May 1-7; 87(18):27, 29, 30. PubMed ID: 2023837
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
    Schellekens LA; Roland R; Lequin RM
    Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
    [No Abstract]   [Full Text] [Related]  

  • 9. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum prolactin and the suppression of lactation.
    Weinstein D; Ben-David M; Polishuk WZ
    Br J Obstet Gynaecol; 1976 Sep; 83(9):679-82. PubMed ID: 788774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
    Scapin F; Buonaccorsi S; Tronconi G; Pellicciotta G; Pontiroli AE
    Eur J Clin Pharmacol; 1982; 22(2):181-3. PubMed ID: 7047172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
    Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
    Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of puerperal lactation. A double blind study of bromocriptine and placebo.
    Dewhurst CJ; Harrison RF; Biswas S
    Acta Obstet Gynecol Scand; 1977; 56(4):327-31. PubMed ID: 341635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lactation by cyclofenil and bromocriptine.
    Thorbert G; Akerlund M
    Br J Obstet Gynaecol; 1983 Aug; 90(8):739-42. PubMed ID: 6411113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
    Walker S
    Br J Clin Pharmacol; 1975 Aug; 2(4):368P-369P. PubMed ID: 788734
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of puerperal lactation: evaluation of bromocriptine and placebo.
    Bhardwaj N
    Aust N Z J Obstet Gynaecol; 1979 Aug; 19(3):154-7. PubMed ID: 391210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
    Walker S; Groom G; Davis RH; Hibbard BM; Griffiths K
    Lancet; 1975 Nov; 2(7940):842-4. PubMed ID: 53330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.